Share the Video:

Biopharma Perspective on the Psychedelics Space

Dan Grossman, Fabrice Beretta, Murali Gopalakrishnan, Edny Inui

This panel explores the potential for partnerships, acquisitions, and internal R&D as established pharmaceutical players begin to assess whether and how to engage with psychedelic innovation. 

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

Related Videos